Ilsung Is Co., Ltd.
KSC: 003120.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Seok-geun Yoon
- Employees
- 224
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩148.9B
- Website
- https://www.ilsungis.com
Loading 003120…
Loading profile data…Frequently asked questions about 003120
What does Ilsung Is Co., Ltd. (003120.KS) do?
Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardio...
Where does 003120.KS trade?
Ilsung Is Co., Ltd. (003120.KS) trades on the Korea Exchange.
What sector is 003120.KS in?
Ilsung Is Co., Ltd. (003120.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ilsung Is Co., Ltd.?
Seok-geun Yoon is the chief executive officer of Ilsung Is Co., Ltd. (003120.KS).
Where is Ilsung Is Co., Ltd. headquartered?
Ilsung Is Co., Ltd. is headquartered in South Korea.
Does 003120.KS pay a dividend?
Yes — Ilsung Is Co., Ltd. (003120.KS) paid a trailing twelve-month dividend of KRW 1200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 003120.KS go public?
Ilsung Is Co., Ltd. (003120.KS) completed its initial public offering in 2000.